Skip to main content

Table 2 Descriptive characteristics

From: Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency

Characteristic

Group I average results (n =43)

Group II average results (n =42)

P-value

Age

49.8

49.6

0.98

BMI

35.65

36.0

0.98

WC (cm)

118.64

120.26

0.98

SP (mmHg)

128.43

130.12

0.98

DP (mmHg)

85.26

86.05

0.98

F.test

3.85

3.80

0.98

HbA1c

8.26

8.43

0.98

Leptin

21.46

23.19

0.98

TC

211.17

207.28

0.98

TG

185.6

182.21

0.98

HDL

55.50

54.0

0.98

LDL

102.95

99.58

0.98

  1. Data are expressed as mean ± SD. BMI: body mass index; Chol: cholesterol; DP: diastolic blood pressure; F. test: free testosterone; HbA1c: glycosylated hemoglobin; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; SP: systolic blood pressure; TC: total cholesterol; TG: triglyceride; WC: waist circumference.